Company Profile

Year Established : 2006
Total Assets(USD) : 500,000 to 99,999,999
Total Number of Staff : 100-500
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:

Zhejiang Changming Pharmaceutical Co., Ltd, established in 2006, is the subsidiary of Zhejiang Shengda Group. Changming specializes in research, development, production and marketing of cardiovascular and other therapeutic drug related APls and intermediates. Changming is one of leading suppliers of pharmaceutical grade ACE inhibitor APIs and intermediates. The leading products include: Enalapril, Ramipril, Lisinopril, Benfotiamine, Doxofylline,etc.

Certificates/Standards
PharmaSources Customer Service